Gland Pharma Limited has informed the Exchange regarding a press release dated November 15, 2023, titled "Gland Pharma receives tentative approval from the United States Food and Drug Administration (US FDA) for Angiotensin II for Injection, 2.5 mg/ ml Single-Dose Vial".